Thyrotoxic periodic paralysis: A retrospective, observational study from India

Verma, Vishesh; Kumar, Yogesh; Kotwal, Narendra; Upreti, Vimal; Kumar, K V S Hari; Singh, Yashpal; Menon, Anil S.

doi:10.4103/ijmr.ijmr_335_18

Cited by 11 publications

(7 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Cases of TPP have been reported with thyroiditis, toxic adenoma, or toxic nodular goiter. 4 TPP is commonly misdiagnosed in western countries perhaps because of its rarity in these regions of the world, subtle signs of hyperthyroidism on presentation, and its similarities to familial periodic paralysis (FPP). The prevalence of TPP in non‐Asian populations is 0.1–0.2 percent, or about one‐tenth of the prevalence seen in Asian countries.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Recurrent thyrotoxic periodic paralysis with normokalemia in a 36‐year‐old man: A case report

Hassen

Ali

Khan

et al. 2021

Clinical Case Reports

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

“… 6 Early diagnosis and management of hypokalemia and hyperthyroidism lead to favorable outcomes. 4 We present a case of a young male with Graves’ disease who developed TPP in the presence of normokalemia.…”

Section: Introductionmentioning

confidence: 99%

Recurrent thyrotoxic periodic paralysis with normokalemia in a 36‐year‐old man: A case report

Hassen

Ali

Khan

et al. 2021

Clinical Case Reports

View full text Add to dashboard Cite

show abstract

“…3 Thyrotoxicosis is the most common cause of acquired periodic paralysis. 4 In the absence of a family history of paralysis, renal tubular acidosis should also be considered. 5 Symptoms of hyperthyroidism may not always be evident in patients, or muscle paralysis could be the first manifestation of thyrotoxicosis.…”

Section: Discussionmentioning

confidence: 99%

Thyrotoxic Hypokalemic Periodic Paralysis: A Case Report

ESENBUĞA

Aydemir

Ersoy

2022

Turkish Journal of Internal Medicine

View full text Add to dashboard Cite

show abstract

“…A European study has reported that hyperthyroidism prevalence in people who are ethnically white is slightly higher than that in other ethnic groups (38). Other studies have also suggested that thyroid-related disease incidence varies among ethnic groups (39)(40)(41).…”

Section: Discussionmentioning

confidence: 99%

Hyperthyroidism Prevalence in China After Universal Salt Iodization

Wang

Teng

et al. 2021

Front. Endocrinol.

View full text Add to dashboard Cite

BackgroundUniversal salt iodization (USI) was implemented in mainland China in 1996. The prevalence of hyperthyroidism and its risk factors now require examination.MethodsData were acquired from a nationwide Thyroid, Iodine, and Diabetes Epidemiological survey (TIDE 2015–2017) of 78,470 subjects from 31 provinces. Iodine status, and thyroid hormones and antibodies were measured. ResultsAfter two decades of USI, the prevalence of overt hyperthyroidism (OH), Graves’ disease (GD), severe subclinical hyperthyroidism (severe SCH), and mild subclinical hyperthyroidism (mild SCH) in mainland China was 0.78%, 0.53%, 0.22%, and 0.22%, respectively. OH and GD prevalence were higher in women than in men (OH: 1.16% vs. 0.64%, P<0.001; GD: 0.65% vs. 0.37%, P<0.001).Prevalence was significantly decreased after 60 years-of-age compared with 30–39 years-of-age (OH:0.61% vs. 0.81%, P<0.001; GD: 0.38% vs. 0.57%, P<0.001).Excessive iodine(EI) and deficient iodine(DI) were both related to increased prevalence of OH (odds ratio [OR] 2.09, 95% confidence interval [CI] 1.68–2.59; OR1.35, 95%CI 1.07–1.72, respectively); however, only deficient iodine was associated with increased prevalence of GD (OR1.67, 95%CI 1.30–2.15). Increased thyroid peroxidase antibody and thyroglobulin antibody levels were significantly associated with prevalence of OH and GD, but not severe SCH and mild SCH. Although hyperthyroidism was more prevalent in women, the association disappeared after adjusting for other factors such as antibody levels.ConclusionOH and GD prevalences in mainland China are stable after two decades of USI. Iodine deficiency, elevated thyroid antibody levels, and middle age are the main risk factors for OH and GD. The severe SCH population, rather than the mild SCH population, shows similar characteristics to the OH population.

show abstract

Thyrotoxic periodic paralysis: A retrospective, observational study from India

Cited by 11 publications

References 22 publications

Recurrent thyrotoxic periodic paralysis with normokalemia in a 36‐year‐old man: A case report

Recurrent thyrotoxic periodic paralysis with normokalemia in a 36‐year‐old man: A case report

Thyrotoxic Hypokalemic Periodic Paralysis: A Case Report

Hyperthyroidism Prevalence in China After Universal Salt Iodization

Contact Info

Product

Resources

About